The growth of precision medicine and the emergence of new, targeted therapies are revolutionizing
how cancer is treated. As a result, there is a critical need for insight into the “how” and “why” behind
biomarker testing in oncology.
BrandImpactDx addresses this need, capturing key information on testing rates and the types of tests used – directly from the oncologists and pathologists using them.